Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 18, 2025 08:00 ET | Source: Nutriband Inc.

Nutriband Inc. Signs Letter of Intent with Qvanta Group of Companies to Explore Advanced Technology Solutions for Abuse-Deterrent Pharmaceutical Innovation Strategic Exploration

Quanta LOI
December 18, 2025 07:00 ET | Source: Nutriband Inc.

Nutriband Differentiates Prescription Fentanyl from Illicit Fentanyl in Response to United States Executive Order Designating Fentanyl as a Weapon of Mass Destruction

Fentanyl designation Response
December 17, 2025 08:45 ET | Source: Tiziana Life Sciences Ltd.

Tiziana Life Sciences Doses First Patient in Phase 2 Alzheimer’s Clinical Trial

First Patient Dosed with Intranasal Foralumab in Randomized, Placebo-Controlled Phase 2 TrialBuilds on Recent Evidence of Persistent Neuroinflammation in Alzheimer’s Patients Treated with Anti-Amyloid...
December 09, 2025 08:33 ET | Source: Bleichmar Fonti & Auld

MLTX LAWSUIT ALERT: MoonLake Immunotherapeutics Hit with Securities Fraud Class Action after Drug Trial Results – Contact BFA Law if You Suffered Losses

MoonLake Immunotherapeutics Hit with Securities Fraud Class Action after Drug Trial Results – Contact BFA Law if You Suffered Losses
November 24, 2025 08:30 ET | Source: Gelteq Limited

Gelteq Announces Positive Preclinical Results Demonstrating Enhanced Bioavailability Using Its Proprietary Gel-Based Drug Delivery Platform

MELBOURNE, Australia, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Gelteq Limited (“Gelteq” or the “Company”), a clinical and science-based company specialising in gel-based oral delivery solutions, today...
November 20, 2025 07:30 ET | Source: MicrobiotiX

MicrobiotiX and West Africa Centre for Innovative Research and Care in Ghana Sign MoU to Advance Clinical Development of Bacteriophage Therapeutics and Combat AMR·MDR in Africa

MicrobiotiX and KATH sign MoU to advance clinical bacteriophage therapies against AMR·MDR and expand treatment options for patients in Africa.
November 13, 2025 08:00 ET | Source: Genosafe

GenoSafe étend son leadership en expertise analytique avec l’ouverture de nouveaux laboratoires aux standards internationaux pour soutenir la filière des thérapies innovantes

GenoSafe étend son leadership en expertise analytique avec l’ouverture de nouveaux laboratoires aux standards internationaux pour soutenir la filière des thérapies innovantes Évry-Courcouronnes, le...
November 13, 2025 08:00 ET | Source: Genosafe

GenoSafe strengthens its leadership in analytical expertise with the opening of new GMP-compliant laboratories to support the advanced therapies sector

GenoSafe strengthens its leadership in analytical expertise with the opening of new GMP-compliant laboratories to support the advanced therapies sector Évry-Courcouronnes, France, November 16th, 2025...
November 12, 2025 07:01 ET | Source: Monogram Health

Monogram Health Announces New Executives to Oversee its U.S. Operations

Nashville, Tenn., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Today, Monogram Health, the leading multi-specialty provider of in-home, evidence-based care for patients with multiple chronic conditions,...
November 07, 2025 16:05 ET | Source: InflaRx N.V.

InflaRx to Announce Topline Data from Phase 2a Clinical Trial of INF904 in Hidradenitis Suppurativa and Chronic Spontaneous Urticaria

Company expects to host a webcast to discuss the topline data on Monday, November 10 at 8:00 AM EST / 2:00 PM CETCompany also expects to publish third quarter 2025 financial results on the same day...